Dr Reddy's Laboratories, is getting ready to delist its Netherlands-based speciality pharma company - OctoPlus NV from Euronext as the Indian drug makers have acquired 98.6% of its shares. The entity will start the squeeze-out proceedings in order to acquire the remaining shares not tendered and not held by it or OctoPlus.
Indian drug major had announced the plan to acquire OctoPlus NV for about 27.4 million euros on October 22 last year. According to the agreement, the company made an open offer to purchase all outstanding shares of OctoPlus at an offer price of 0.52 euro in cash for each share.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1872.60 |
| Dr. Reddys Labs. | 1382.70 |
| Cipla | 1459.35 |
| Zydus Lifesciences | 1115.70 |
| Lupin | 2379.00 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: